RARECELLS INC.

Market Reports 📊 7 Reports

1. Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Feb 2024| Analyst - BCC Publishing| Code - BIO126E

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

2. Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

Published - Mar 2022| Analyst - BCC Publishing| Code - PHM153C

BCC Research Market Report for Circulating Tumor Cell (CTC) Diagnostics. Global CTC Diagnostics Technologies market trends, with CAGRs through 2026.

3. Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Jun 2021| Analyst - John Bergin| Code - BIO126D

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

4. Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Apr 2021| Analyst - John Bergin| Code - BIO150D

BCC Market Research Report for global liquid biopsy research tools, liquid biopsy biomarkers, technologies, services and diagnostics markets.

5. Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023

Published - Jun 2019| Analyst - BCC Publishing| Code - HLC238A

Get an overview of the global markets for liquid biopsy technologies, applications, industry subsegments along with analyses of global market trends with data from 2017, 2018 and projections of CAGRs

6. Liquid Biopsy with Emphasis on NIPT: Global Markets to 2023

Published - May 2019| Analyst - BCC Publishing| Code - HLC235A

The global NIPT market was valued at $1.9 billion in 2018 & is projected to grow at a CAGR of 14.1% to reach a forecast size of $3.7 billion by 2023. Also get insight into liquid biopsy Market.

7. Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Apr 2019| Analyst - John Bergin| Code - BIO150C

The global liquid biopsy market should reach $6.1 billion by 2023 from $2.4 billion in 2018 at a compound annual growth rate of 20.8% for the period 2018 to 2023.